ISOLYTE Isosorbide Mononitrate 60mg Sustained Release Tablet 1's
ISOLYTE-TMUIHZ
Discreet Packaging
FDA-registered Products
FDA-licensed Pharmacies
Indications/Uses
Angina pectoris; Congestive heart failure
Administration
Should be taken on an empty stomach.
Contraindications
Severe hypotension, hypertrophic obstructive cardiomyopathy, constrictive pericarditis, cardiac tamponade, aortic or mitral valve stenosis, acute circulatory failure/shock, circulatory collapse, cardiogenic shock, acute MI with low left ventricular filling pressure, conditions associated with increased intracranial pressure (e.g. cerebral haemorrhage, head trauma), closed-angle glaucoma, marked anaemia, hypovolaemia. Concomitant use with phosphodiesterase-5 (PDE-5) inhibitors (e.g. sildenafil) or riociguat.
Special Precautions
Patient with recent history of MI, inferior wall MI and suspected right ventricular infarctions; hypothyroidism, hypoxaemia, malnutrition, hypothermia. Not indicated for the treatment of acute angina attacks. Avoid abrupt withdrawal. Severe renal and hepatic impairment. Elderly. Pregnancy and lactation.
Storage
Store between 20-30°C. Protect from light and moisture.
MedsGo Class
Anti-Anginal Drugs
Features
Brand
ISOLYTE
Full Details
Dosage Strength
60mg
Drug Ingredients
- Isosorbide Mononitrate
Drug Packaging
Sustained Release Tablet 1's
Generic Name
Isosorbide Mononitrate
Dosage Form
Sustained Release Tablet
Registration Number
DRP-11608
Drug Classification
Prescription Drug (RX)
Please sign in so that we can notify you about a reply